Qiagen NV
QGEN42.688USD
+0.038+0.09%
시장 운영 시간 （ET）시세는 15분 지연됩니다
9.23B시가총액
110.37P/E TTM
자세한 내용은 Qiagen NV 회사
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
회사 정보
회사 코드QGEN
회사 이름Qiagen NV
상장일Sep 01, 1996
설립일1996
CEOMr. Thierry Bernard
직원 수5765
유형Ordinary Share
회계 연도 종료Sep 01
주소Hulsterweg 82
도시VENLO
증권 거래소NYSE Consolidated
국가Netherlands
우편 번호5912 PL
전화31773556600
웹사이트https://www.qiagen.com/
회사 코드QGEN
상장일Sep 01, 1996
설립일1996
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Lawrence A. Rosen
Mr. Lawrence A. Rosen
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
수익 분석
통화: USD업데이트 시간: Sun, Apr 6
통화: USD업데이트 시간: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
사업별USD
이름
수익
비율
Consumables and Related Revenues
1.76B
88.98%
Instrumentation
218.00M
11.02%
지역별USD
이름
수익
비율
United States
942.01M
47.62%
Europe & Middle East & Africa
648.49M
32.78%
Asia, Pacific & Rest of the World
298.15M
15.07%
Other Americas
89.56M
4.53%
사업별
지역별
사업별USD
이름
수익
비율
Consumables and Related Revenues
1.76B
88.98%
Instrumentation
218.00M
11.02%
주주
업데이트 시간: Fri, May 16
업데이트 시간: Fri, May 16
주주 통계
유형
주주 통계
주주
비율
Wellington Management Company, LLP
11.29%
MFS Investment Management
11.20%
The Vanguard Group, Inc.
4.06%
Amundi Asset Management, SAS
1.94%
BlackRock Institutional Trust Company, N.A.
1.92%
Other
69.59%
주주 통계
주주
비율
Wellington Management Company, LLP
11.29%
MFS Investment Management
11.20%
The Vanguard Group, Inc.
4.06%
Amundi Asset Management, SAS
1.94%
BlackRock Institutional Trust Company, N.A.
1.92%
Other
69.59%
유형
주주
비율
Investment Advisor/Hedge Fund
45.76%
Investment Advisor
23.21%
Research Firm
3.25%
Hedge Fund
3.22%
Sovereign Wealth Fund
1.87%
Holding Company
1.17%
Bank and Trust
1.13%
Pension Fund
1.10%
Individual Investor
0.44%
Other
18.86%
기관 주식 보유
업데이트 시간: Mon, Jan 20
업데이트 시간: Mon, Jan 20
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
987
158.50M
73.34%
-14.17M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
2023Q1
1001
160.07M
74.44%
-9.45M
2022Q4
1009
160.10M
74.55%
-10.38M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Wellington Management Company, LLP
23.29M
10.78%
+2.11M
+9.98%
Jan 31, 2025
The Vanguard Group, Inc.
8.54M
3.95%
+77.90K
+0.92%
Dec 31, 2024
Amundi Asset Management, SAS
4.71M
2.18%
-798.61K
-14.50%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
19.32M
8.94%
-13.86K
-0.07%
Mar 04, 2025
Norges Bank Investment Management (NBIM)
3.96M
1.83%
-111.67K
-2.74%
Dec 31, 2024
DWS Investments UK Limited
2.14M
0.99%
+712.11K
+50.02%
Dec 31, 2024
BlackRock Asset Management Deutschland AG
2.75M
1.27%
+37.88K
+1.40%
Mar 31, 2025
더 보기
관련 ETF
업데이트 시간: Tue, May 6
업데이트 시간: Tue, May 6
이름
비율
Global X Genomics & Biotechnology ETF
4.13%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.99%
Global X Telemedicine & Digital Health ETF
3.49%
Invesco Biotechnology & Genome ETF
2.61%
VanEck Biotech ETF
1.43%
Franklin Genomic Advancements ETF
1.41%
T Rowe Price International Equity ETF
1.4%
ROBO Global Healthcare Technology & Innovation ETF
1.37%
Global X DAX Germany ETF
1.21%
WisdomTree BioRevolution Fund
1.16%
더 보기
Global X Genomics & Biotechnology ETF
비율4.13%
First Trust Nasdaq Lux Digi Health Solutions ETF
비율3.99%
Global X Telemedicine & Digital Health ETF
비율3.49%
Invesco Biotechnology & Genome ETF
비율2.61%
VanEck Biotech ETF
비율1.43%
Franklin Genomic Advancements ETF
비율1.41%
T Rowe Price International Equity ETF
비율1.4%
ROBO Global Healthcare Technology & Innovation ETF
비율1.37%
Global X DAX Germany ETF
비율1.21%
WisdomTree BioRevolution Fund
비율1.16%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
날짜
유형
비율
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
